CA-A Cancer Journal for Clinicians

Papers
(The H4-Index of CA-A Cancer Journal for Clinicians is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials18429
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey12939
Breast cancer in a transgender man7575
Cancer treatment and survivorship statistics, 20252229
Near majority of adults favor R ratings for films with smoking2170
Issue Information2056
1652
482
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer353
Colorectal cancer statistics, 2026275
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians215
Correction to “Self‐collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline”200
Screening for colorectal cancer177
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types130
Cancer statistics 2024: All hands on deck130
Most patients with cancer are not undergoing germline genetic testing129
Multicancer detection tests: What we know and what we don’t know110
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies109
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision‐making108
Blood tests for colorectal cancer—Hype ahead of evidence?103
Cancer statistics, 202695
Reviewer acknowledgement 202593
92
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach85
82
Issue Information79
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial75
More care needed for cancer caregivers68
Health insurance status and cancer stage at diagnosis and survival in the United States68
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review65
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine64
The evolving landscape of tissue‐agnostic therapies in precision oncology54
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future51
Medicaid expansion increases survival for patients with cancer49
Interventional gastroenterology in oncology47
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma46
Study identifies risk factors that may lead to secondary cancers46
Does distance deter male fertility preservation?45
Lung cancer screening guidelines: Smoking matters, not quitting44
Overlooked barriers to implementation of geriatric assessment42
Study assesses normal tissue effects after axillary radiotherapy for early breast cancer41
0.073932886123657